In response to an extraordinary demand by supply chain participants following the Omicron outbreak, Freight & Trade Alliance (FTA) has partnered with Protective Health, a leading provider of medical supplies, as a part of a consortia to provide members with access to Therapeutic Goods Administration (TGA) approved Rapid Antigen Tests (RATs).
Urgent action was needed in response to the recent state and federal government re-assessment on testing regimes. Once PCR testing was no longer a sustainable option, FTA engaged leading business consultants, BDO Australia, to find a large volume, reputable provider of RAT kits solution for members to maximise the safety of staff and allow continuity of sustainable business operations.
Protective Health was identified as an ideal partner with a proven track record as a leading large-scale supplier of quality medical supplies since the first peak of COVID-19. Located at Port Botany, HubX was selected as the warehouse and logistics provider to manage the projected large scale import volumes.
In terms of the product, the TGA approved the Clungene Covid-19 Antigen Rapid Test on 7 January 2022 with a very high sensitivity and specificity rating for use by companies and individuals for self-testing purposes. Furthermore, the Protective Health products undergo independent quality testing to the highest standards by various global authorities to ensure they are compliant in all of the regions they serve.
Further detail and links to consortia participants' web sites are available in the FTA Media Release - refer HERE |